logo
Breadcrumbs Image

Contrast Agents for Magnetic Resonance Imaging MRI Market

Contrast Agents for Magnetic Resonance Imaging MRI Market

Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Research Report 2021 Professional Edition


Date: Apr-2021 | Id: MACRC-46877 | Geographical Scope: Global | Publisher: HNY Research

The research team projects that the Contrast Agents for Magnetic Resonance Imaging (MRI) market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

By Market Players:
GE Healthcare (US)
J.B. Chemicals and Pharmaceuticals (India)
Guerbet (France)
Bracco Imaging (Italy)
Unijules Life Sciences (India)
Bayer HealthCare (Germany)
Taejoon Pharm (South Korea)
Daiichi Sankyo (Japan)
Lantheus (US)
Spago Nanomedicine (Sweden)
Jodas (India)
Magnus Health (India)

By Type
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media

By Application
Radiology
Interventional Radiology
Interventional Cardiology

By Regions/Countries:
North America
United States
Canada
Mexico

East Asia
China
Japan
South Korea

Europe
Germany
United Kingdom
France
Italy
Russia
Spain
Netherlands
Switzerland
Poland

South Asia
India
Pakistan
Bangladesh

Southeast Asia
Indonesia
Thailand
Singapore
Malaysia
Philippines
Vietnam
Myanmar

Middle East
Turkey
Saudi Arabia
Iran
United Arab Emirates
Israel
Iraq
Qatar
Kuwait
Oman

Africa
Nigeria
South Africa
Egypt
Algeria
Morocoo

Oceania
Australia
New Zealand

South America
Brazil
Argentina
Colombia
Chile
Venezuela
Peru
Puerto Rico
Ecuador

Rest of the World
Kazakhstan

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global  market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Contrast Agents for Magnetic Resonance Imaging (MRI) 2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2022-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Contrast Agents for Magnetic Resonance Imaging (MRI) Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).
Markat Analysis by Application Type: Based on the Contrast Agents for Magnetic Resonance Imaging (MRI) Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Contrast Agents for Magnetic Resonance Imaging (MRI) market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Get Started with Request an Overview
Get Started with Download Brochure
Get Started with Request Methodology
Get Started with Share Customization
Get Started with Submit RFP
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue
1.4 Market Analysis by Type
1.4.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Barium-based Contrast Media
1.4.3 Iodinated Contrast Media
1.4.4 Gadolinium-based Contrast Media
1.4.5 Microbubble Contrast Media
1.5 Market by Application
1.5.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Application: 2022-2027
1.5.2 Radiology
1.5.3 Interventional Radiology
1.5.4 Interventional Cardiology
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market
1.8.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Contrast Agents for Magnetic Resonance Imaging (MRI) Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Market Share by Region (2016-2021)
3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Revenue Market Share by Region (2016-2021)
3.3 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume
3.3.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2016-2021)
3.3.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume
3.4.1 East Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2016-2021)
3.5.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2016-2021)
3.6.1 South Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2016-2021)
3.7.1 Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2016-2021)
3.8.1 Middle East Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2016-2021)
3.9.1 Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2016-2021)
3.10.1 Oceania Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2016-2021)
3.11.1 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2016-2021)
3.11.2 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume (2016-2021)
3.12.1 Rest of the World Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Market Share by Type (2016-2021)
14.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Revenue Market Share by Type (2016-2021)
14.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Volume by Application (2016-2021)
15.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Contrast Agents for Magnetic Resonance Imaging (MRI) Business
16.1 GE Healthcare (US)
16.1.1 GE Healthcare (US) Company Profile
16.1.2 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.1.3 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 J.B. Chemicals and Pharmaceuticals (India)
16.2.1 J.B. Chemicals and Pharmaceuticals (India) Company Profile
16.2.2 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.2.3 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Guerbet (France)
16.3.1 Guerbet (France) Company Profile
16.3.2 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.3.3 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Bracco Imaging (Italy)
16.4.1 Bracco Imaging (Italy) Company Profile
16.4.2 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.4.3 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Unijules Life Sciences (India)
16.5.1 Unijules Life Sciences (India) Company Profile
16.5.2 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.5.3 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Bayer HealthCare (Germany)
16.6.1 Bayer HealthCare (Germany) Company Profile
16.6.2 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.6.3 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Taejoon Pharm (South Korea)
16.7.1 Taejoon Pharm (South Korea) Company Profile
16.7.2 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.7.3 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Daiichi Sankyo (Japan)
16.8.1 Daiichi Sankyo (Japan) Company Profile
16.8.2 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.8.3 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Lantheus (US)
16.9.1 Lantheus (US) Company Profile
16.9.2 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.9.3 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Spago Nanomedicine (Sweden)
16.10.1 Spago Nanomedicine (Sweden) Company Profile
16.10.2 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.10.3 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Jodas (India)
16.11.1 Jodas (India) Company Profile
16.11.2 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.11.3 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Magnus Health (India)
16.12.1 Magnus Health (India) Company Profile
16.12.2 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Specification
16.12.3 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Cost Analysis
17.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Contrast Agents for Magnetic Resonance Imaging (MRI)
17.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors List
18.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Contrast Agents for Magnetic Resonance Imaging (MRI) (2022-2027)
20.2 Global Forecasted Revenue of Contrast Agents for Magnetic Resonance Imaging (MRI) (2022-2027)
20.3 Global Forecasted Price of Contrast Agents for Magnetic Resonance Imaging (MRI) (2016-2027)
20.4 Global Forecasted Production of Contrast Agents for Magnetic Resonance Imaging (MRI) by Region (2022-2027)
20.4.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2022-2027)
20.4.3 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2022-2027)
20.4.7 Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2022-2027)
20.4.9 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Contrast Agents for Magnetic Resonance Imaging (MRI) Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
21.2 East Asia Market Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
21.3 Europe Market Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Countriy
21.4 South Asia Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
21.5 Southeast Asia Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
21.6 Middle East Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
21.7 Africa Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
21.8 Oceania Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
21.9 South America Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
21.10 Rest of the world Forecasted Consumption of Contrast Agents for Magnetic Resonance Imaging (MRI) by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer

Add to Cart

Single User

$ 2890.00

Site License

$ 4335.00

Enterprisewide

$ 5780.00